Megan B. Salt

561 citations
4 papers · 412 indexed · h-index 4
Topics
Melanoma and MAPK Pathways (2 papers)Cancer Cells and Metastasis (1 paper)Bone Metabolism and Diseases (1 paper)
Partner nations
United States

In The Last Decade

Megan B. Salt

4 papers receiving 407 citations

Peers

Megan B. Salt
Comparison fields: 5 of 55
  • Molecular Biology 302
  • Oncology 151
  • Cancer Research 73
  • Pulmonary and Respiratory Medicine 56
  • Cell Biology 48
Replace Yahao Bu with:
Yahao Bu United States
Marco Mazzoletti Italy
Joanne Berry United Kingdom
Deanna N. Parke United States
Chung‐Min Yeh Taiwan
Robert D. Kendig United States
Jonathan W. Haskins United States
Silvia Licciulli Italy
Étienne Lemieux Canada
Ihor Yakymovych Sweden
Megan B. Salt relative to Yahao Bu United States Yahao Bu's profile →
Citations per field
00.5×2.9×
Yahao Bu · 1×
Citations per year

Countries citing papers authored by Megan B. Salt

Since Specialization
Citations

This map shows the geographic impact of Megan B. Salt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan B. Salt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan B. Salt more than expected).

Fields of papers citing papers by Megan B. Salt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan B. Salt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan B. Salt. The network helps show where Megan B. Salt may publish in the future.

Co-authorship network of co-authors of Megan B. Salt

This figure shows the co-authorship network connecting the top 25 collaborators of Megan B. Salt. A scholar is included among the top collaborators of Megan B. Salt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan B. Salt. Megan B. Salt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
#WorkIndexed citations
1 55
2 85
3 259
4
Focal adhesion kinase signaling controls cyclic tensile strain enhanced collagen I-induced osteogenic differentiation of human mesenchymal stem cells.
13

About Megan B. Salt

Megan B. Salt is a scholar working on Immunology and Allergy, Oncology and Cancer Research, having authored 4 papers that have together received 412 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (2 papers), Cancer Cells and Metastasis (1 paper) and Bone Metabolism and Diseases (1 paper). The work is most often cited by research in Oncology (151 citations), Cancer Research (73 citations) and Molecular Biology (302 citations). Megan B. Salt has collaborated with scholars based in United States. Frequent co-authors include Stephan Gysin, Frank McCormick, Amy Young, Frank McCormick, Sourav Bandyopadhyay, Alma L. Burlingame, Juan A. Osés-Prieto, Byron Hann, James T. Webber and Martin L. Sos. Their work appears in journals such as Cell Reports, Cancer Discovery and Genes & Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026